Ardent Health, Inc.

For the period ended Dec 31, 2025. Filed Mar 16, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 16, 2026

ARDT$17.30+8.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share amounts)

	December 31,
	2025 (1)	2024 (1)
Assets
Current assets:
Cash and cash equivalents	$709,601		$556,785
Accounts receivable	686,102		743,031
Inventories	118,593		115,093
Prepaid expenses	112,646		113,749
Other current assets	431,882		304,093
Total current assets	2,058,824		1,832,751
Property and equipment, net	935,769		861,899
Operating lease right of use assets	292,651		248,040
Operating lease right of use assets, related party	915,599		929,106
Goodwill	879,451		852,084
Other intangible assets	89,335		76,930
Deferred income taxes	6,888		12,321
Other assets	111,691		142,969
Total assets	$5,290,208		$4,956,100
Liabilities and Equity
Current liabilities:
Current installments of long-term debt	$23,444		$9,234
Accounts payable	457,936		401,249
Accrued salaries and benefits	296,260		295,117
Other accrued expenses and liabilities	268,904		239,824
Total current liabilities	1,046,544		945,424
Long-term debt, less current installments	1,075,782		1,085,818
Long-term operating lease liability	260,600		221,443
Long-term operating lease liability, related party	904,632		919,313
Self-insured liabilities	241,050		227,048
Other long-term liabilities	76,636		34,697
Total liabilities	3,605,244		3,433,743
Commitments and contingencies (see Note 13)
Redeemable noncontrolling interests	(1,250)		1,158
Equity:
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; no shares issued and outstanding	—		—
Common stock, par value $0.01 per share; 750,000,000 shares authorized; 142,864,171 and 142,747,818 shares issued and outstanding as of December 31, 2025 and 2024, respectively	1,429		1,428
Additional paid-in capital	788,472		754,415
Accumulated other comprehensive (loss) income	(3,610)		9,737
Retained earnings	501,607		365,796
Equity attributable to Ardent Health, Inc.	1,287,898		1,131,376
Noncontrolling interests	398,316		389,823
Total equity	1,686,214		1,521,199
Total liabilities and equity	$5,290,208		$4,956,100

(1)As of December 31, 2025 and 2024, the consolidated balance sheets included total liabilities of consolidated variable interest entities of $335.1 million and $306.4 million, respectively. Refer to Note 2, Summary of Significant Accounting Policies, for further discussion.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.